HealthcareServices

Global Whole Genome And Exome Sequencing Market Set for Strong Expansion, Reaching $7.63 Billion With 24.8% CAGR by 2030

March 4, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the whole genome and exome sequencing market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Whole Genome And Exome Sequencing Market in 2030?

The market size for whole genome and exome sequencing has experienced exponential growth in recent years. It is projected to expand from $2.52 billion in 2025 to $3.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 24.8%. This historical growth can be attributed to advancements in next-generation sequencing technologies, the rising application of genomics in cancer research, the expansion of academic genomics initiatives, declining sequencing costs, and the development of precision medicine programs.

The whole genome and exome sequencing market is projected to experience rapid expansion over the coming years. Its valuation is anticipated to reach $7.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.8%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the growing implementation of extensive genomics initiatives, the increasing incorporation of AI into genomic analysis, broader acceptance of clinical genomics, escalating investments in sequencing infrastructure, and the rising need for tailored treatment approaches. Key developments expected during the forecast period encompass the wider embrace of comprehensive genome sequencing, the expanding application of sequencing in oncology diagnostics, a heightened need for integrated WGS and WES workflows, the proliferation of population genomics research, and an intensified concentration on high-throughput sequencing technologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What Drivers Are Influencing Production Trends In The Whole Genome And Exome Sequencing Market?

The future growth of the whole genome and exome sequencing market is projected to be driven by the increasing need for personalized medicine. Personalized medicine represents a medical treatment strategy that customizes healthcare decisions and interventions for each patient, considering their distinct genetic, environmental, and lifestyle factors. Within this approach, whole genome and exome sequencing delivers a comprehensive analysis of an individual’s genetic makeup, which facilitates tailored healthcare choices and interventions based on their unique genetic, environmental, and lifestyle aspects. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based organization focused on promoting personalized medicine, noted that the FDA approved 26 personalized medicines. These approvals encompassed 20 new molecular entities (NMEs) and 6 gene-/cell-based therapies, accounting for approximately 38% of all newly approved therapeutic NMEs. Thus, the escalating demand for personalized medicine is propelling the expansion of the whole genome and exome sequencing market.

Which Segment Groups Are Influencing The Whole Genome And Exome Sequencing Market?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

What Trends Are Expected To Impact The Competitive Landscape Of The Whole Genome And Exome Sequencing Market?

Leading companies operating in the whole genome and exome sequencing markets are increasingly focusing on developing advanced technological solutions, such as ultra-fast NGS (next-generation sequencing) analysis, to achieve a competitive advantage. Ultra-fast NGS analysis is a technological advancement that allows for the processing of next-generation sequencing (NGS) data at an exceptionally rapid pace, substantially decreasing the time needed for genomic data analysis. As an illustration, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, introduced its ultra-fast NGS analysis platform. This platform provides functionalities such as processing a whole genome in 25 minutes for $1 in cloud computing costs, thereby encouraging efficiency, affordability, and scalability; its technological innovation considerably improves genomic data analysis speed and accessibility, making it highly significant in the whole genome and exome sequencing market by facilitating prompt decision-making and wider acceptance of personalized medicine.

Who Are The Core Companies Influencing Trends In The Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V, BGI Genomics, Novogene Co., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., GENEWIZ Inc., 10x Genomics Inc., MGI Tech Co. Ltd., Clear Labs Inc., Macrogen Inc., PierianDx Inc., Invitae Corporation, Fulgent Genetics Inc., SOPHiA GENETICS SA, Azenta US Inc., Gene by Gene Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Regions Are Projected To Dominate The Whole Genome And Exome Sequencing Market In The Coming Years?

North America was the largest region in the whole genome and exome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Whole Genome And Exome Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2026, By The Business Research Company

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Whole Exome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795